MOLLY MOLOZNIK: Open Payments
NPI 1164587226 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,124 in 47 payments from 16 companies in 2025. Trend: 2023 $2,226 · 2024 $2,281 · 2025 $1,124
Food & beverage: $1,059Education: $65
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $231 |
| GENZYME CORPORATION | 5 | $156 |
| Janssen Biotech, Inc. | 4 | $124 |
| UCB, Inc. | 6 | $123 |
| LEO Pharma Inc. | 3 | $79 |
| Regeneron Healthcare Solutions, Inc. | 2 | $64 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| Organon LLC | 5 | $46 |
| Lilly USA, LLC | 2 | $45 |
| Botanix SB Inc | 2 | $43 |
Products named: DUPIXENT, TREMFYA, Bimzelx, BOTOX, SKYRIZI, ADBRY, COSENTYX, VTAMA.
Industry payments across AZ — which companies pay providers there.
